Cargando…
Neoantigen vaccine: an emerging tumor immunotherapy
Genetic instability of tumor cells often leads to the occurrence of a large number of mutations, and expression of non-synonymous mutations can produce tumor-specific antigens called neoantigens. Neoantigens are highly immunogenic as they are not expressed in normal tissues. They can activate CD4+ a...
Autores principales: | Peng, Miao, Mo, Yongzhen, Wang, Yian, Wu, Pan, Zhang, Yijie, Xiong, Fang, Guo, Can, Wu, Xu, Li, Yong, Li, Xiaoling, Li, Guiyuan, Xiong, Wei, Zeng, Zhaoyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708248/ https://www.ncbi.nlm.nih.gov/pubmed/31443694 http://dx.doi.org/10.1186/s12943-019-1055-6 |
Ejemplares similares
-
Emerging role of tumor-related functional peptides encoded by lncRNA and circRNA
por: Wu, Pan, et al.
Publicado: (2020) -
Neoantigen vaccine: An emerging immunotherapy for hepatocellular carcinoma
por: Chen, Pu, et al.
Publicado: (2021) -
Natural killer group 2D receptor and its ligands in cancer immune escape
por: Duan, Shixin, et al.
Publicado: (2019) -
Proteomic Analysis of the Molecular Mechanism of Lovastatin Inhibiting the Growth of Nasopharyngeal Carcinoma Cells
por: Mo, Yongzhen, et al.
Publicado: (2019) -
The role of Wnt signaling pathway in tumor metabolic reprogramming
por: Mo, Yongzhen, et al.
Publicado: (2019)